Vildagliptin for treating general peripheral neuropathies
AssigneeNovartis AG
InventorThomas Edward Hughes
Life of this patent
Estimating the term…
Abstract
The present invention is directed to use of a Dipeptidyl peptidase IV inhibitor for treating general peripheral neuropathies, in particular, the present invention provides a method for the prevention, delay of progression, or the treatment of general peripheral neuropathies in a patient in need thereof, by administering an effective amount of vildagliptin or a pharmaceutically acceptable salt thereof.
Claims2
1-26. (canceled)
A method for the prevention, delay of progression, or the treatment of general peripheral neuropathies, said method comprising administration to a patient in need thereof, of a therapeutically effective amount of vildagliptin or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.